Cushing's syndrome due to ectopic ACTH production by (neuroendocrine) prostate carcinoma

Pituitary

Volumn 12, Issue 3, 2009, Pages 280-283

  Alwani, R A ^a   Neggers, S J C M M ^a   van der Klift, M ^b   Baggen, M G A ^b   Leenders, G J L H ^a   van Aken, M O ^a   van der Lely, A J ^a   de Herder, W W ^a   Feelders, R A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b IKAZIA HOSPITAL   (Netherlands)

Author keywords

ACTH staining; Cushing's syndrome; Ectopic ACTH; Neuroendocrine differentiation; Prostate cancer

Indexed keywords

6 FLUORODOPA F 18; ANTIINFECTIVE AGENT; CORTICOTROPIN; LACTATE DEHYDROGENASE; MIFEPRISTONE; NEURON SPECIFIC ENOLASE;

ADRENALECTOMY; ADULT; ARTICLE; BODY MASS; CASE REPORT; CORTICOTROPIN BLOOD LEVEL; CORTICOTROPIN RELEASE; CUSHING SYNDROME; DEATH; GENERALIZED EDEMA; HUMAN; HYPERCORTISOLISM; HYPERPIGMENTATION; LACTATE DEHYDROGENASE BLOOD LEVEL; MALE; METASTASIS POTENTIAL; MULTIPLE ORGAN FAILURE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CARCINOMA; PROTEIN BLOOD LEVEL; SEPSIS; TUMOR LOCALIZATION; WEIGHT GAIN;

ADRENOCORTICOTROPIC HORMONE; CUSHING SYNDROME; FATAL OUTCOME; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; SMALL CELL LUNG CARCINOMA;

EID: 67849106829     PISSN: 1386341X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11102-008-0100-z     Document Type: Article

References (29)

1. Ilias I, Torpy DJ, Pacak K, Mullen N, Wesley RA, Nieman LK (2005) Cushing's syndrome due to ectopic corticotropin secretion: Twenty years' experience at the National Institutes of Health. J Clin Endocrinol Metab 90:4955-4962 Medline. doi: 10.1210/jc.2004-2527
2. Newell-Price J, Bertagna X. Grossman a B, Nieman LK (2006) Cushing's syndrome. Lancet 367:1605-1617 Medline. doi: 10.1016/ S0140-6736(06)68699-6
3. Isidori a M. Kaltsas GA, Pozza C, Frajese V, Newell-Price J, Reznek RH, Jenkins PJ, Monson JP, Grossman a B, Besser GM (2006) The ectopic adrenocorticotropin syndrome: Clinical features, diagnosis, management, and long-term follow-up. J Clin Endocrinol Metab 91:371-377 Medline. doi: 10.1210/jc.2005-1542
4. Salgado LR, Fragoso MC, Knoepfelmacher M, Machado MC, Domenice S, Pereira MA, De Mendonca BB (2006) Ectopic ACTH syndrome: Our experience with 25 cases. Eur J Endocrinol 155:725-733 Medline. doi: 10.1530/ eje.1.02278
5. Parkin DM, Bray FI, Devesa SS (2001) Cancer burden in the year 2000. The global picture Eur J Cancer 37(Suppl 8):S4-S66 Medline. doi: 10.1016/ S0959-8049(01)00267-2
6. Jemal A, Thomas A, Murray T, Thun M (2002) Cancer statistics, 2002. CA Cancer J Clin 52:23-47 Medline.
7. Abrahamsson PA (1999) Neuroendocrine differentiation in prostatic carcinoma. Prostate 39:135-148 Medline. doi: 10.1002/ (SICI)1097-0045(19990501)39:2 < 135::AID-PROS9 > 3.0.CO;2-S
8. Debes JD, Tindall DJ (2004) Mechanisms of androgen-refractory prostate cancer. N Engl J Med 351:1488-1490 Medline. doi: 10.1056/NEJMp048178
9. Di Sant'agnese PA (1995) Neuroendocrine differentiation in prostatic carcinoma. Recent findings and new concepts. Cancer (Suppl) 75:1850-1859
10. Mosca A, Berruti A, Russo L, Torta M, Dogliotti L (2005) The neuroendocrine phenotype in prostate cancer: Basic and clinical aspects. J Endocrinol Invest 28:141-145 Medline
11. Shariff a H, Ather MH (2006) Neuroendocrine differentiation in prostate cancer. Urology 68:2-8
12. Taplin ME, George DJ, Halabi S et al (2005) Prognostic significance of plasma chromogranin A levels in patients with hormone-refractory prostate cancer treated in cancer and leukemia group B 9480 study. Urology 66:386-391 Medline. doi: 10.1016/j.urology.2005.03.040
13. Vashchenko N, Abrahamsson PA (2005) Neuroendocrine differentiation in prostate cancer: Implications for new treatment modalities. Eur Urol 47:147-155 Medline. doi: 10.1016/j.eururo.2004.09.007
14. Fjellestad-Paulsen A, Abrahamsson PA, Bjartell A et al (1988) Carcinoma of the prostate with Cushing's syndrome. A case report with histochemical and chemical demonstration of immunoreactive corticotropin-releasing hormone in plasma and tumoral tissue. Acta Endocrinol (Copenh) 119:506-516 Medline
15. Haukaas SA, Halvorsen OJ, Nygaard SJ, Paus E (1999) Cushing's syndrome in prostate cancer. An aggressive course of prostatic malignancy. Urol Int 63:126-129 Medline. doi: 10.1159/000030431
16. Hussein WI, Kowalyk S, Hoogwerf BJ (2002) Ectopic adrenocorticotropic hormone syndrome caused by metastatic carcinoma of the prostate: therapeutic response to ketoconazole. Endocr Pract 8:381-384 Medline
17. Lovern WJ, Fariss BL, Wettlaufer JN, Hane S (1975) Ectopic ACTH production in disseminated prostatic adenocarcinoma. Urology 5:817-820 Medline. doi: 10.1016/0090-4295(75)90365-9
18. Newmark SR, Dluhy RG, Bennett a H (1973) Ectopic adrenocorticotropin syndrome with prostatic carcinoma. Urology 2:666-668 Medline. doi: 10.1016/0090-4295(73)90333-6
19. Rickman T, Garmany R, Doherty T, Benson D, Okusa MD (2001) Hypokalemia, metabolic alkalosis, and hypertension: Cushing's syndrome in a patient with metastatic prostate adenocarcinoma. Am J Kidney Dis 37:838-846 Medline
20. Pivonello R, Ferone D, Lamberts SW, Colao A (2005) Cabergoline plus lanreotide for ectopic Cushing's syndrome. N Engl J Med 352:2457-2458 Medline. doi: 10.1056/NEJM200506093522322
21. Francia G, Davi MV, Montresor E, Colato C, Ferdeghini M, Lo Cascio V (2006) Long-term quiescence of ectopic Cushing's syndrome caused by pulmonary neuroendocrine tumor (typical carcinoid) and tumorlets: spontaneous remission or therapeutic effect of bromocriptine? J Endocrinol Invest 29:358-362 Medline
22. Chu JW, Matthias DF, Belanoff J, Schatzberg A. Hoffman a R, Feldman D (2001) Successful long-term treatment of refractory Cushing's disease with high-dose mifepristone (RU 486). J Clin Endocrinol Metab 86:3568-3573 Medline. doi: 10.1210/jc.86.8.3568
23. Nieman LK, Chrousos GP, Kellner C et al (1985) Successful treatment of Cushing's syndrome with the glucocorticoid antagonist RU 486. J Clin Endocrinol Metab 61:536-540 Medline
24. Sciarra A, Cardi A, Dattilo C, Mariotti G, Di Monaco F, Di Silverio F (2006) New perspective in the management of neuroendocrine differentiation in prostate adenocarcinoma. Int J Clin Pract 60:462-470 Medline. doi: 10.1111/j.1742-1241.2006.00750.x
25. Fixemer T, Remberger K, Bonkhoff H (2002) Apoptosis resistance of neuroendocrine phenotypes in prostatic adenocarcinoma. Prostate 53:118-123 Medline. doi: 10.1002/pros.10133
26. Stewart PM, Gibson S, Crosby SR et al (1994) ACTH precursors characterize the ectopic ACTH syndrome. Clin Endocrinol (Oxf) 40:199-204 Medline
27. Coates PJ, Doniach I, Howlett TA, Rees LH, Besser GM (1986) Immunocytochemical study of 18 tumours causing ectopic Cushing's syndrome. J Clin Pathol 39:955-960 Medline. doi: 10.1136/jcp.39.9.955
28. Delisle L, Boyer MJ, Warr D et al (1993) Ectopic corticotropin syndrome and small-cell carcinoma of the lung. Clinical features, outcome, and complications Arch Intern Med 153:746-752 Medline. doi: 10.1001/ archinte.153.6.746
29. Gewirtz G, Yalow RS (1974) Ectopic ACTH production in carcinoma of the lung. J Clin Invest 53:1022-1032 Medline